U-51605 – 500 µg

Brand:
Cayman
CAS:
64192-56-9
Storage:
-80
UN-No:
De Minimis - 1231 / 3

U-51605 is a stable analog of the endoperoxide prostaglandin H2 (PGH2). It is an inhibitor of both prostacyclin (PGI) and thromboxane (TX) synthases with more selectivity towards PGI synthase. U-51605 is also a partial agonist at TP receptors.{817} In human foreskin fibroblasts, U-51605 inhibits PGI synthase at a concentration of 2.8 µM, whereas, human platelet TX synthase is inhibited at a concentration of 5.6 µM.{818,486} At concentrations up to 1 µM, U-51605 reduced the release of prostacyclin in SHR aorta elicited by the calcium ionophore A-23187 with no effect on TXA2 production and yet significantly increased PGE2 and PGF2α release.{18479}  

 

Out of stock

SKU: - Category:

Description

A stable analog of PGH2 that inhibits both PGI and TX synthases with more selectivity towards PGI synthase; a partial agonist at TP receptors


Formal name: 9α,11α-azoprosta-5Z,13E-dien-1-oic acid

Synonyms: 

Molecular weight: 332.5

CAS: 64192-56-9

Purity: ≥98%

Formulation: A solution in methyl acetate


Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Blood||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway